Dialysis patients may fight frailty with home video workouts

NCT ID NCT06313892

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This pilot trial tests whether dialysis patients can follow a supervised exercise program at home using video calls. Participants will do 40 to 45 minute sessions three times a week for 12 weeks. The study focuses on whether this approach is practical and safe, and whether it might improve physical function and reduce frailty.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Home-based synchronous tele-exercise delivered via video conferencing
What this could lead to
If it works, this could offer a convenient way for dialysis patients to exercise at home, potentially improving physical function and reducing frailty.
What could go wrong
This is a small pilot study focused on feasibility, not proof of effectiveness. The exercise may be hard to sustain, and benefits might not be confirmed in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Mar 2024

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Being Aged 18 years and over 2. Regular in-center HD 3 times a week 3. Completed at least 1 year of stable HD history 4. Without myocardial infarction within past 3 months 5. Permission from their doctors 6. Have decision making capacity to enable them to give informed consent to take part in the study 7. Have access to a smart device (e.g. smart phone, laptop or tablet), and have internet access Exclusion Criteria: 1. Unstable cardiac status (angina, decompensated congestive heart failure, severe vascular stenosis, uncontrolled arrhythmias, etc.). 2. Active infection or acute medical illness. 3. Hemodynamic instability. 4. Labile glycemic control. 5. Unstable HD treatment or an ongoing change or titration in the medication regimen. 6. Inability to exercise due to severe mobility limitations, although modifications will be permitted for amputations with prosthesis or seated exercise. 7. Severe musculoskeletal pain at rest or with minimal activity. 8. Inability to sit, stand, or walk unassisted (walking aids such as a cane or walker will be allowed). 9. Shortness of breath at rest or during activities of daily living (NYHA Class IV). 10. Participation in exercise ≥3 times per week addressing ≥2 exercise domains

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End stage renal disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Khorshid Dialysis Center

    Isfahan, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.